Related Experiment Video

Updated: Aug 7, 2025

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
09:47

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

Published on: June 2, 2022

2.4K

Ephedrine to treat intraoperative hypotension in infants: what is the target?

Jurgen C de Graaff1, Peter Frykholm2

  • 1Department of Anaesthesiology, ADRZ-Erasmus MC, Goes, the Netherlands.

British Journal of Anaesthesia
|March 11, 2023
PubMed

Insights

Off-label medication use in pediatric anesthesia is common due to limited evidence-based dosing for children. New studies are crucial to establish safe and effective pediatric dosing regimens, especially for infants, to avoid adverse effects.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Clinical Trials

Background:

  • Off-label medication use is prevalent in pediatric anesthesia due to a lack of evidence-based dosing guidelines for children.
  • Pediatric dosing often relies on adult parameters or local practices, increasing the risk of unanticipated adverse effects.
  • Infant-specific dose-finding studies are critically needed to address this evidence gap.

Discussion:

  • The challenges of off-label drug administration in pediatric anesthesia require careful consideration.
  • Defining and treating hypotension in pediatric anesthesia presents complexities, with ambiguity in treatment goals (e.g., restoring mean arterial pressure to baseline vs. exceeding a threshold).
  • A recent ephedrine dose-finding study underscores the distinct pharmacokinetic and pharmacodynamic properties of pediatric patients compared to adults.

Key Insights:

  • Limited evidence-based dosing regimens necessitate frequent off-label medication use in pediatric anesthesia.
  • Pediatric dosing requires specific studies due to unique physiological responses, distinct from adult parameters.
  • Clearer definitions and treatment strategies for anesthetic-induced hypotension in children are essential.

Outlook:

  • Future research should prioritize well-designed, infant-focused dose-finding studies for commonly used anesthetic agents.
  • Standardizing definitions and treatment protocols for pediatric hypotension will improve patient safety.
  • Promoting evidence-based practices in pediatric anesthesia is vital for optimizing patient outcomes.

Keywords:
encephalopathyephedrinehypotensionoff-label usepaediatric anaesthesia

More Related Videos

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

363
In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus11:59

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus

Published on: April 28, 2023

360

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
876
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
57
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
806
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
895
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
554
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
175